MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell MalignanciesLiqin Liu, Ezio Bonvini, Vatana Long et al.|Clinical Cancer Research|2016Cited by 69